HIGHLIGHTS
SUMMARY
Groups Parameters Control APAN ETO APAN+ETO EST EST+APAN EST+ETO EST+APAN+ETO AFP (ng/mL) CEA (ng/mL) Anti-dsDNA (U/mL) Data are presented as mean ± SE, n=8. p and amp;lt; 0.01, (*) indicates a significant difference compared to the control group, and_(**) indicates a significant difference compared to the EST group. The resulting data showed a significant decrease in tumor weight and volume after the treatment by APAN or/and ETO, which may be due to the ability of APAN to intercalate into GC-rich sequences and . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.